Chemsex linked with increased diagnoses of HIV and other sexually transmitted infections

May 23, 2018, Wiley

Chemsex—the use of crystallised methamphetamine, mephedrone, γ-hydroxybutyrate or γ-butyrolactone and to a lesser extent cocaine and ketamine to facilitate sex—has emerged as a new phenomenon in the UK and across Europe amongst gay, bisexual and other men who have sex with men (GBMSM). A new HIV Medicine study reveals that chemsex disclosure in sexual health settings is associated with higher rates of new diagnoses of HIV, Hepatitis C, and other sexually transmitted infections.

For the study, researchers reviewed information on all GBMSM attending 2 London sexual health clinics over a 13 month period. Those who reported that they had participated in chemsex were 5-times more likely to have a new diagnosis of HIV than those who had not participated in chemsex.

Although it was not possible to determine if chemsex causes HIV infection, the investigators note that use of drugs in sexual settings and alcohol has been linked with condomless anal sex and other behaviours predisposing to HIV transmission.

"These are the first published data clearly demonstrating a link between a new HIV diagnosis and Chemsex," said senior author Dr. Aseel Hegazi, of St. George's University Hospital Foundation Trust, in London. "At risk GBMSM participating in Chemsex should access prevention strategies such as , or PrEP, and there is a need to increase public awareness regarding the potential consequences of Chemsex."

Explore further: 'Chemsex' needs to become a public health priority

More information: HIV Medicine, DOI: 10.1111/hiv.12629

Related Stories

'Chemsex' needs to become a public health priority

November 3, 2015
Chemsex - sex under the influence of illegal drugs - needs to become a public health priority, argue experts in The BMJ this week.

More gay men than ever getting tested for HIV—but 1 in 4 still never had a test

June 20, 2016
More gay and bisexual men than ever are getting tested for HIV, according to new data from the National Gay Men's Sex Survey. The survey is the largest of its kind in the UK and sheds light on the sexual health of men who ...

Campaigner with drug past warns of 'chemsex' HIV link

July 20, 2017
The sexual health expert credited with coining the term "chemsex" told AFP that drug-laced sexual encounters are boosting HIV infections in gay communities.

Research suggests stigma could inhibit access to HIV prevention drug

December 8, 2016
The first study to explore United Kingdom men's perceptions of PrEP – a new HIV prevention treatment – has found that their opinions are negatively influenced by social stigma. The article published in Cogent Medicine ...

Protecting young adults' sexual health

April 10, 2018
Gilla Shapiro studies clinical psychology at McGill. She earned her BA and MA in Social and Political Sciences at the University of Cambridge and dual degrees in public policy and public administration at the Hertie School ...

PrEP and targeted intervention strategies effective in high risk adolescent sexual minority males

January 8, 2018
Pre-exposure prophylaxis (PrEP) along with targeted implementation strategies have the potential to significantly reduce HIV incidence among high risk, adolescent sexual minority males (ASMM), according to a recent study ...

Recommended for you

New research highlights why HIV-infected patients suffer higher rates of cancer

December 5, 2018
AIDS patients suffer higher rates of cancer because they have fewer T-cells in their bodies to fight disease. But new research examines why HIV-infected patients have higher rates of cancer—among the leading causes of death ...

Focus on resistance to HIV offers insight into how to fight the virus

November 30, 2018
Of the 40 million people around the world infected with HIV, less than one per cent have immune systems strong enough to suppress the virus for extended periods of time. These special immune systems are known as "elite controllers." ...

Patients with rare natural ability to suppress HIV shed light on potential functional cure

November 27, 2018
Researchers at Johns Hopkins have identified two patients with HIV whose immune cells behave differently than others with the virus and actually appear to help control viral load even years after infection. Moreover, both ...

Scientists unveil promising new HIV vaccine strategy

November 26, 2018
A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.

Influential U.S. panel backs PrEP HIV-prevention pills

November 20, 2018
(HealthDay)—For the first time, a highly influential panel of experts says doctors should offer a daily pill to prevent HIV transmission to people who are at high risk for infection with the AIDS-causing virus.

Majority of HIV persistence during ART due to infected cell proliferation

November 17, 2018
A majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originated from cellular proliferation, not viral replication, according to new research published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.